Antioxidants and AP-1 activation: A brief overview

Immunobiology

Volumn 198, Issue 1-3, 1997, Pages 273-278

  Ǵomez Del Arco, Pablo ^a   Martínez Martínez, Sara ^a   Calvo, Victor ^b   Armesilla, Angel Luis ^a   Redondo, Juan Miguel ^a,c  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 2642657303     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80047-2     Document Type: Article

References (19)

1. KARIN, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483.
2. ANGEL, P., and M. KARIN. 1991. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochem. Biophys. acta 1072: 129.
3. TREISMAN, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell. Biol. 8: 205.
4. SU, B., and M. KARIN. 1996. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8: 402.
5. HILL, C. S., and R. TREISMAN. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell. 80: 199.
6. KYRIAKIS, J. M., and J. AVRUCH. 1996. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271: 24313.
7. CAHILL, M. A., R. JANKNECHT, and A. NORDHEIM. 1996. Signalling pathways: Jack of all cascades. Curr. Biol. 6: 16.
8. JANKNECHT, R., and T. HUNTER. 1997. Activation of the Sap-1a transcription factor by the c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase. J. Biol. Chem. 272: 4219.
9. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12: 2005.
10. SCHENK, H., M. KLEIN, W. ERDBRÜGGER, W. DRÖGE, and K. SCHULZE-OSTHOFF. 1994. Distinct effects of thioredoxin and other antioxidants on the activation of NF-κB and AP-1. Proc. Natl. Acad. Sci. 91: 1672.
11. ARAGONÉS, J., C. LÓPEZ-RODRIGUEZ, A. CORBÍ, P. GÓMEZ DEL ARCO, M. LÓPEZ-CABRERA, M. O. DE LANDÁZURI, and J. M. REDONDO. 1996. Dithiocarbamates trigger differentiation a induction of CD11c gene through AP-1 in the myeloid lineage. J. Biol. Chem. 271: 10924.
12. 2-terminal kianse) is a target for antioxidants in T lymphocytes. J. Biol. Chem. 271: 26335.
13. RUSHMORE, T. H., M. R. MORTON, and C. B. PICKETT. 1991. The antioxidant responsive element. J. Biol. Chem. 266: 11632.
14. LI, Y., and K. JAISWAL. 1992. Regulation of human NAD(P)H-quinone oxidoreductase gene. J. Biol. Chem. 267: 15097.
15. YAO, K.-S., S. XANTHOUDAKIS, T. CURRAN, and P. J. O'DWYER. 1994. Activation of AP-1 and of nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol. 14: 5997.
16. RUPEC, R. A., and P. A. BAEUERLE. 1995. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-κB. Eur. J. Biochem. 234: 632.
17. LÓPEZ-RODRÍGUEZ, C. H. C. KLUIN-NELEMANS, and A. CORBÍ. 1996. AP-1 regulates the basal and developmentally induced transcription of the CD11c leukocyte integrin gene. J. Immunol. 156: 3780.
18. MUÑOZ, C., M. C. CASTELLANOS, A. ALFRANCA, A. VARA, M. A. ESTEBAN, J. M. REDONDO, and M. O. DE LANDÁZURI. 1996. Transcriptional up-regulation of intracellular adhesion molecule-1 in human endothelial cells by the antioxidant pyrrolidine dithiocarbamate involves the activation of activating protein-1. J. Immunol. 157: 3587.
19. MUÑOZ, C., D. PASCUAL-SALCEDO, M. C. CASTELLANOS, A. ALFRANCA, J. ARAGONÉS, A. VARA, J. M. REDONDO, and M. O. DE LANDÁZURI. 1996. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-κB and AP-1 transcription factors activity. Blood 88: 3482.